• OPEN AN ACCOUNT
Indian Indices
Sensex
83,878.17 301.93
( 0.36%)
Global Indices
Nasdaq
49,609.72 84.64
(0.17%)
Dow Jones
6,998.08 10.80
(0.15%)
Hang Seng
51,918.01 800.75
(1.57%)
Nikkei 225
10,139.59 14.99
(0.15%)
Forex
USD-INR
90.22 0.30
(0.34%)
EUR-INR
104.95 0.05
(0.04%)
GBP-INR
120.87 0.01
(0.01%)
JPY-INR
0.57 0.00
(-0.40%)

EQUITY - MARKET SCREENER

SBI Life Insurance Company Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
540719
INE123W01016
182.4507922
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SBILIFE
85.71
210238.26
EPS(TTM)
Face Value()
Div & Yield %
24.46
10
0.13
 

Solara Active Pharma Sciences' Mangalore unit completes USFDA inspection
Nov 19,2025
Solara Active Pharma Sciences announced that its multi-product manufacturing facility at Mangalore, Karnataka has successfully completed the inspection carried out by the US Food and Drug Administration (US FDA) between 25 to 29 August 2025. The Agency has issued an EIR (Establishment Inspection Report) on 18th Nov 2025 and determined that the inspection classification of the facility is “Voluntary Action Indicated (VAI)” and concluded this inspection as closed.